Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
4.905
-0.015 (-0.30%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Aptevo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 6 | 9 | 2 | 3 | 11 | 37 | |
| Market Cap Growth | 314.03% | 309.61% | -36.51% | -68.79% | -70.52% | -75.46% | |
| Enterprise Value | -11 | -7 | -0 | -10 | -1 | 4 | |
| Last Close Price | 4.98 | 9.43 | 1551.60 | 106077.48 | 1359667.12 | 4612319.05 | |
| PE Ratio | - | - | - | - | 1.36 | - | |
| PS Ratio | - | - | - | - | 3.49 | 3.00 | |
| PB Ratio | 0.29 | 0.51 | 0.45 | 0.28 | 0.61 | 30.34 | |
| P/TBV Ratio | 0.34 | 0.51 | 0.45 | 0.28 | 0.61 | 30.34 | |
| EV/Sales Ratio | - | - | - | - | - | 0.34 | |
| Debt / Equity Ratio | 0.27 | 0.27 | 1.14 | 0.44 | 0.55 | 13.75 | |
| Net Debt / Equity Ratio | -0.98 | -0.98 | -0.70 | -0.94 | -0.70 | -23.30 | |
| Net Debt / EBITDA Ratio | 0.65 | 0.65 | 0.14 | 0.41 | 0.46 | 1.40 | |
| Net Debt / FCF Ratio | 0.66 | 0.66 | 0.14 | 0.98 | 0.60 | 1.26 | |
| Asset Turnover | - | - | - | - | 0.07 | 0.22 | |
| Quick Ratio | 3.57 | 3.57 | 1.40 | 2.34 | 2.89 | 1.40 | |
| Current Ratio | 3.82 | 3.82 | 1.72 | 2.64 | 3.15 | 1.51 | |
| Return on Equity (ROE) | -234.61% | -234.61% | -284.28% | -123.53% | 73.10% | -330.24% | |
| Return on Assets (ROA) | -76.87% | -76.87% | -76.06% | -61.12% | -39.42% | -24.29% | |
| Return on Capital Employed (ROCE) | -124.40% | -124.40% | -262.20% | -163.90% | -112.30% | -98.00% | |
| Earnings Yield | -441.24% | -294.15% | -1119.63% | -512.92% | 73.80% | -77.12% | |
| FCF Yield | -434.87% | -289.90% | -1103.63% | -345.56% | -193.53% | -60.69% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.